Enovix Corporation
—- Market cap
- —
- Debt
- +$529.37M
- Cash
- −$512.04M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ENVX stock price vs AMRN: inconclusive — current versus $4.05 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMRN's multiple
Implied fair value · at ENVX's multiple
Needs ENVX P/S.
Snapshot Sep 8, 2026, 2:35 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ENVX FY 2025 (ended Dec 28, 2025) · AMRN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 97% equity / 3% debt · EV / Revenue 27.35x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Enovix Corporation · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
AMARIN CORP PLC\UK · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.95x
0.39x
Net debt / EBITDA
Leverage against operating earnings
-0.15x
3.79x
Cash and equivalents
Liquid reserves on the balance sheet
$512.04M
$302.59M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
QuantumScape Corp
ENVX vs QS
Eos Energy Enterprises, Inc.
ENVX vs EOSE
Microvast Holdings, Inc.
ENVX vs MVST
AEHR TEST SYSTEMS
ENVX vs AEHR
LIGAND PHARMACEUTICALS INC
ENVX vs LGND
Harmony Biosciences Holdings, Inc.
ENVX vs HRMY
SUPERNUS PHARMACEUTICALS, INC.
ENVX vs SUPN
Viatris Inc
ENVX vs VTRS
Organon & Co.
ENVX vs OGN
INCYTE CORP
ENVX vs INCY
$529.37M
$177.39M
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.